Perfil
Nick DeLong is the founder of Evolved Capital, Inc. He previously worked as the Head of Business Development at Tris Pharma, Inc. and as the Vice President of Corporate Development at iBio, Inc. He holds a doctorate degree from the University of Pennsylvania and an undergraduate degree from Rutgers University- Newark.
Antiguos cargos conocidos de Nick DeLong.
| Empresas | Cargo | Fin |
|---|---|---|
| IBIO, INC. | Corporate Officer/Principal | 01/06/2024 |
Evolved Capital, Inc.
Evolved Capital, Inc. Packaged SoftwareTechnology Services Develops web-based tool | Fundador | - |
Tris Pharma, Inc.
Tris Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and delivers therapeutics for ADHD, pain, addiction & central nervous system disorders | Corporate Officer/Principal | - |
Formación de Nick DeLong.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 5 |
|---|---|
University of Pennsylvania
University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
iBio, Inc.
iBio, Inc. Pharmaceuticals: OtherHealth Technology Engages in the development and commercialization of vaccines and therapeutic proteins | Health Technology |
Tris Pharma, Inc.
Tris Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and delivers therapeutics for ADHD, pain, addiction & central nervous system disorders | Health Technology |
Rutgers University- Newark
Rutgers University- Newark Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Evolved Capital, Inc.
Evolved Capital, Inc. Packaged SoftwareTechnology Services Develops web-based tool | Technology Services |
- Bolsa de valores
- Insiders
- Nick DeLong
















